# CIVIC Assertion6 (AID6) record, along with one of its six Evidence Lines
# See  https://civicdb.org/events/assertions/6/summary (website record), https://civicdb.org/api/assertions/6 (API payload)


  - id: civic-data:AID6            
    type: TherapeuticEfficacyStatement 
    description: "EGFR L858R positive NSCLC is sensitive to afatinib."    
    asserted_proposition:
      id: civic-data:Proposition001
      subject:                                   # Protein allele value object for the EGFR L858R variant       
        _id: ga4gh:VA.C0OEtMYqCBfqfxG1XUH73Vn9ax-9x6gO 
        type: Allele
        state:
          sequence: R
          type: SequenceState
        location:
          _id: ga4gh:VSL.CBfqfC0O-9x6EtMYq1XUH73Vn9axgOxG
          type: SequenceLocation
          interval:
            type: SimpleInterval            
            start: 858
            end: 858
          sequence_id: ga4gh:SQ.rvra4fpLT_m155UmcSC-zA5ZK0wi-qoD
        predicate: 
          code: ex:001                            # Placeholder code for this predicate - as no code exists in CIViC or community ontologies
          label: associated_with_sensitivity_to 
        object:                                   # The Treatment with which the variant is associated with a response to
          id: civic-term:drug_146          
          type: TherapeuticIntervention     
          drug: 
            - code: CHEBI:61390
              label: Afatinib            
        alleleOriginQualifier:                    # A custom qualifier defined in the TherapeuticEfficacyStatement Profile
          code: GENO:0000882         
          label: somatic allele origin
        indicated_condition_qualifier:            # The 'disease' for which the treatment is administered 
          id: civic-term:disease_8
          type: GeneticCondition
          label: Lung Non-small Cell Carcinoma 
          disease:            
            - code: doid:3908
              label: Lung Non-small Cell Carcinoma
              url: http://www.disease-ontology.org/?id=DOID:3908    
        subject_descriptor:                       # A Descriptor object that provides additional useful metadata about the subject variant of this statement, which  is not accommodated by its value object representation
          - id: civic-data:variationdescriptor_33        
            type: VariationDescriptor
            value_object_id : ga4gh:VA.C0OEtMYqCBfqfxG1XUH73Vn9ax-9x6gO         
            value_object_label: NP_005219.2:p.Leu858Arg      
            xrefs: [cosmic:COSM6224, clinvar:16609, dbSNP:rs121434568]
            alternate_label: [EGFR L858R]
            value_object_expression: 
              - value: NC_000007.13:g.55259515T>G 
                system: ghgvs
              - value: NM_005228.5:c.2573T>G
                system: chgvs 
              - value: NP_005219.2:p.Leu858Arg
                system: phgvs      
            molecule_context:                      
              code: SO:0000104               
              label: polypeptide
              system: http://purl.obolibrary.org/obo/SO        
       
    was_specified_by: 
      - id: civic-data:Method_1                   # CIViC curator SOP method that guided curation, interpretation, and scoring of evidence supporting the final TE Statement
        type: Method
        label: CIViC Variant Curation SOP
        reference: 
          - id: civic_data:source832
            document_type: Publication
            identifier:
              - PMID:31779674    
      - id: civic-data:Method_2                   # AMP-ASCO Guidelines used to determine the overall level of evidence for the Statement
        type: Method
        label: AMP-ASCO-CAP Guidelines
        reference: 
          - id: civic_data:source832
            document_type: Publication
            identifier:
              - PMID:27993330  
    evidence_level:                               # Overall level of evidence deemed to support the TE Statement
      - code: civic-term:001  
        label: Tier I - Level A             

    has_evidence_from_source:
      - id: civic-data:source_592     # Duplicates pub already attached to the Study Result - may not want to capture here as well.
        type: Publication   
        identifier:                  
          - pmid:25923549      
      - id: civic-data:document_001   # These are clinical care guidelines, but CIViC treats them as a source of evidence.  May get represented as an Evidence Line/EID?  
        type: Publication
        label: NCCN Non-Small Cell Lung Cancer Guideline (v3.2018) 

    qualified_contribution:
      - id: civic-data:Contrib001                # We assume the submitter of the record is also the curator who made the knowledge level statement, and thus record this agent as the 'creator' of the Statement.  They are also credited as the 'submitter' in a record-level metadata Contribution object. 
        type: Contribution  
        contribution_made_by: 
          id: civic-data:user_110 
          type: Agent
          identifier: orcid:0000-0001-9815-2288
          label: ArpadDanos
          agentType: 
            - code: foaf:Person
              label: Person
          description: Dr. Danos is a Postdoctoral Researcher in the Griffith Lab, with research interests in developing data and knowledge models which can describe and give structure to clinical and preclinical cancer variant knowledge, and in developing standards to enable efficient trasnfer and communication of this information between groups who are generating and curating this data, as well as with the medical and research community at large, in order to address the curation bottleneck which has arisen with increasing incorporation of NGS technology into clinical as well as research contexts. Dr. Danos is also interested in elucidation of the regulatory structure of the genome, and the role of non-coding mutations in cancer.",    
          affiliation:                         # List of different affiliations the Agent has or had with an Orgnaization (these are associated with the Agent, not a specific Contribution made by the Agent)
            - id: clingen-data:affil_1         # The Agent's current/active affiliation with WashU as a postdoc
              type: Affiliation
              organization: 
                id: civic-data:org_12
                type: Agent
                label: Washington University in Saint Louis
                agentType: 
                  - code: foaf:Organization 
                    label: Organization
                url: https://wustl.edu/
              organizational_role: 
                - code: NCIT:C19925
                  label: Postdoctoral Scholar
              startDate: 2017-06-29
              affiliation_status: 
                code: ex:status_001
                label: active
            - id: clingen-data:affil_2         # The Agent's past/inactive affiliation with WashU as a graduate student        
              type: Affiliation
              organization: 
                id: civic-data:org_12
                type: Agent
                label: Washington University in Saint Louis
                agentType: 
                  - code: foaf:Organization 
                    label: Organization
                url: https://wustl.edu/
              organizational_role: 
                - code: NCIT:C75561
                  label:  Student
              startDate: 2014-09-15
              endDate: 2017-06-22
              affiliation_status: 
                code: ex:status_002
                label: inactive
            - id: clingen-data:affil_3         # The Agent's current/active affiliation with ClinGen as a member of an expert panel
              type: Affiliation
              organization: 
                id: civic-data:org_2
                identifier:
                  - fairsharing:3972
                label: ClinGen
                type: Agent
                agentType: 
                   - code: foaf:Organization 
                     label: Organization
                description: ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research.
                url: https://www.clinicalgenome.org/
              organizational_role: 
                - code: ex:role_001
                  label: Expert Panel Member
              startDate: 2016-01-18
              affiliation_status: 
                code: ex:status_001
                label: active
            - id: clingen-data:affil_4         # The Agent's past/inactive affiliation with the McDonnell Genome Institute (no specific organizational role indicated)
              type: Affiliation
              organization: 
                id: civic-data:org_1
                label: The McDonnell Genome Institute
                type: Agent
                agentType: 
                  - code: foaf:Organization 
                    label: Organization
              startDate: 2014-09-02
              endDate: 2021-04-12
              affiliation_status: 
                code: ex:status_002
                label: inactive
        contributor_role:                      # A role indicating the specific type of Contribution made to the statement
          - code: CRO:0000107
            label: creator role                    
        organizational_context: clingen-data:affil_4    # Indicates that this specific Contribution was made as a expert panel member for ClinGen (one of many affiliations the Agent has, see above)


    has_evidence_line:                         # Only one of the six evidence lines in the source data is included here 
      - id: civic-data:EID879    
        type: EvidenceLine       
        target_proposition: civic-data:Proposition001     # The Proposition (possible fact) against which the evidence is evaluated in this EvidenceLine. It is the same Proposition as that asserted in the root Statement (so just referencing here).          
        evidence_direction:                    # The direction of support interpreted for the evidence item(s) w.r.t the target proposition, as assigned by CIViC curator     
          code: civic-term:002    
          label: supports
        evidence_strength:                     # The strength of support interpreted for the evidence item(s) w.r.t the target proposition, as assigned by CIViC curator 
          code: civic-term:001   
          label: B
        was_specified_by: 
          - id: civic-data:Method_1            # The method guiding curation, interpretation, and scoring of evidence contributing to this EvidenceLine.  
            type: Method
            label: CIViC Variant Curation SOP
            reference: 
              - id: civic-data:source_235
                type: Document   
                documentType:
                  - code: IAO:0000311
                    label: Publication
                identifier:         
                  - pmid:31779674
        qualified_contribution:            #  As above, we assume the submitter of the record is also the curator who generated the information expressed in this EvidenceLine, and thus record this agent as its 'creator'.
          - id: civic-data:Contrib101      
            type: Contribution  
            contribution_made_by: 
              - id: civic-data:user_15
                type: Agent
                label: Malachi Griffith
            contributor_role: 
              - code: CRO:0000107
                label: creator role
            start_date: 2016-01-14T20:16:44.813Z
            end_date: 2016-01-14T20:16:44.813Z      
       has_evidence_item:                     # The clinical trial data/result that was interpreted as evidence in the EvidenceLine
          - id: civic-data:StudyResult001  
            type: StudyResult                  # A StudyResult is a curated, structured summary of a specific set of data generated in a single study   
            study_type: 
              - code: NCIT:C71104
                label: Clinical Trial
            focus:                             # The 'focus' field is optional - and can be used to indicate what entit(ies) the data in the Result is about. Here it is the variation EGFR L858R. 
              - civic-data:vod-33              # The descriptor of the variant is referenced here - and a full representation is not shown here as it is already provided in this record)
            description: A phase III clinical trial (NCT00949650) found that median progression free survival among patients with exon 19 deletions or L858R EGFR mutations (n = 308) was 13.6 months for afatinib and 6.9 months for chemotherapy (HR, 0.47; 95% CI, 0.34 to 0.65; P = 0.001).
            confidence_level:                  # The inherent quality / trustworthiness of the result - here, an 'trust rating' assigned by the CIViC curator
              - code: civic-term:003 
                label: 4-star
            reference:                         # The publication that reported the result
              - id: civic-data:source_592 
                type: Document   
                documentType:
                  - code: IAO:0000311
                    label: Publication
                identifier:            
                  - pmid:25923549           
                title: Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations.
                url: http://www.ncbi.nlm.nih.gov/pubmed/23816960
            data_item:                         # The data items the curator selected to include in this Result object (as they represent evidence relevant to the variant of interest). In the source data, these are described only in the free text description.  In this example, we show how it would look to structure this information. 
              - id: civic-data:data_001
                type: DataItem 
                data_item_type: 
                  - code: NCIT:C28234
                    label: Progression Free Survival
                value: 13.6
                unit: 
                  - code: UO:0000035
                    label: month
              - id: civic-data:data_002
                type: DataItem 
                data_item_type: 
                  - code: NCIT:C93150
                    label: Hazard Ratio
                value: 0.47
                confidence_interval:
                  - id: civic-data:data_003
                    type: DataItem 
                    data_item_type: 
                      - code: STATO:0000231
                        label: 95% confidence interval
                    component_data_item:
                      - id: civic-data:data_004
                        type: DataItem 
                        data_item_type: 
                          - code: STATO:0000314
                            label: upper confidence limit
                        value: 0.65
                      - id: civic-data:data_005
                        type: DataItem 
                        data_item_type: 
                          - code: STATO:0000315
                            label: lower confidence limit
                        value: 0.34
              - id: civic-data:data_006
                type: DataItem 
                data_item_type: 
                  - code: STATO:0000088
                    label: study group population size
                value: 308

        recordMeta:                            # Record Metadata describing provenance of this concrete record of the EvidenceLine 
          - date_last_modified: 2018-02-23T04:31:09.515Z
            qualified_contribution:            # Contributions are one way represent lifecycle actions on CIViC records. This is still evolving modeling in VA-SEPIO.
              - id: civic-data:Contrib102      # Malachi's 'submitter' contribution to this Evidence Line record
                type: Contribution  
                contribution_made_by: 
                  - id: civic-data:user_15
                    type: Agent
                    label: Malachi Griffith
                contributor_role: 
                  - code: CRO:0000105
                    label: submitter role
                start_date: 2016-01-14T20:16:44.813Z
                end_date: 2016-01-14T20:16:44.813Z           

              - id: civic-data:Contrib103       # Obi's 'acceptor' contribution to this Evidence Line record
                type: Contribution  
                contribution_made_by: 
                  - id: civic-data:user_3
                    type: Agent
                    label: Obi Griffith
                contributor_role: 
                  - code: CRO:0000104
                    label: acceptor role
                start_date: 2016-02-09T00:15:24.113Z
                end_date: 2016-02-09T00:15:24.113Z



    recordMeta:                                 # Record Metadata describing provenance of this concrete record of the Statement
      - date_last_modified: 2019-05-22T15:44:02.670Z
        qualified_contribution:
          - id: civic-data:Contrib001           # Arpad's 'submitter' contribution to the Statement record 
            type: Contribution  
            contribution_made_by: 
              - id: civic-data:user_110
                type: Agent
                label: ArpadDanos
                identifier: 
                  - orcid:0000-0001-9815-2288
            contributor_role: 
              - code: CRO:0000105
                label: submitter role
            start_date: 2016-01-27T00:20:51.218Z
            end_date: 2016-01-27T00:20:51.218Z          

          - id: civic-data:Contrib002            # Erica's 'acceptor' contribution to the Statement record 
            type: Contribution
            contribution_made_by: 
              - id: civic-data:user_179
                type: Agent
                label: EricaBarnell
                identifier: 
                  - orcid:0000-0003-1631-1201
            contributor_role: 
              - code: CRO:0000104
                label: acceptor role
            start_date: 2016-07-06T14:48:11.341Z
            end_date: 2016-07-06T14:48:11.341Z







# -----------------------------------------------------------------


#APPENDICES:

# Simplified the example by making the target proposition of the evidence line the same as that of the root Statement (which is the case 99% of the time).
# The actual target proposition in this EID record is:


    has_evidence_line:                         # Only one of the six evidence lines in the source data is included here 
      - id: civic-data:EID879    
        type: EvidenceLine       
        target_proposition:                    # The Proposition (possible fact) against which the evidence is evaluated in this EvidenceLine
          id: civic-data:Proposition002        # Exactly the same S-P-O-Q as Proposition001 in the root Statement (except the disease here is a subtype of the disease in Proposition001)
          subject:                                         
            _id: ga4gh:VA.C0OEtMYqCBfqfxG1XUH73Vn9ax-9x6gO 
            type: Allele
            state:
              sequence: R
              type: SequenceState
           location:
             _id: ga4gh:VSL.CBfqfC0O-9x6EtMYq1XUH73Vn9axgOxG
             type: SequenceLocation
             interval:
               type: SimpleInterval            
               start: 858
               end: 858
             sequence_id: ga4gh:SQ.rvra4fpLT_m155UmcSC-zA5ZK0wi-qoD
          predicate: 
            code: ex:001                            
            label: associated_with_sensitivity_to 
          object:                                   
            id: civic-term:drug_146          
            type: TherapeuticIntervention     
            drug: 
              - code: CHEBI:61390
                label: Afatinib            
          alleleOriginQualifier:                    
            code: GENO:0000882         
            label: somatic allele origin
          indicated_condition_qualifier:            
            id: civic-term:disease_30
            type: GeneticCondition
            label: Lung Adenocarcinoma
            disease:                                # The disease here is a subtype of disease in the root TE Statement (Lung Non-small Cell Carcinoma)
              - code: doid:3910
                label: Lung Adenocarcinoma
            url: "http://www.disease-ontology.org/?id=DOID:3910 

#---------------------------------

# Additional fields that COULD be defined in a StudyResult specialization, and used to structure individual data items from the result.
 #   studyResultType: ClinicalTrialResult
 #   study_size: 308         
 #   median_PFS_drug: 13.6 months
 #   median_PFS_comparator: 6.9 months
 #   hazard_ratio: 0.47; 95% CI, 0.34 to 0.65
 #   p-value: 0.001     